Morgane Mounier

8.0k total citations
40 papers, 731 citations indexed

About

Morgane Mounier is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Morgane Mounier has authored 40 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Morgane Mounier's work include Lymphoma Diagnosis and Treatment (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Morgane Mounier is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Morgane Mounier collaborates with scholars based in France, United Kingdom and Switzerland. Morgane Mounier's co-authors include Marc Maynadié, Alain Monnereau, Milena Sant, Pamela Minicozzi, François Girodon, Roberta De Angelis, Lesley Anderson, Hermann Brenner, Otto Visser and Gemma Osca‐Gelis and has published in prestigious journals such as Blood, Cancer Research and The Lancet Oncology.

In The Last Decade

Morgane Mounier

38 papers receiving 715 citations

Peers

Morgane Mounier
A. H. Goldstone United Kingdom
A. Grigg Australia
Adina Cioc United States
Marie‐Christine Jacob France
Anastasios Raptis United States
Chirayu Auewarakul Thailand
Beenu Thakral United States
Roni Tamari United States
Fabrice Monpoux France
Usama Gergis United States
A. H. Goldstone United Kingdom
Morgane Mounier
Citations per year, relative to Morgane Mounier Morgane Mounier (= 1×) peers A. H. Goldstone

Countries citing papers authored by Morgane Mounier

Since Specialization
Citations

This map shows the geographic impact of Morgane Mounier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgane Mounier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgane Mounier more than expected).

Fields of papers citing papers by Morgane Mounier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgane Mounier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgane Mounier. The network helps show where Morgane Mounier may publish in the future.

Co-authorship network of co-authors of Morgane Mounier

This figure shows the co-authorship network connecting the top 25 collaborators of Morgane Mounier. A scholar is included among the top collaborators of Morgane Mounier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgane Mounier. Morgane Mounier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dantony, Emmanuelle, Zoé Uhry, Mathieu Fauvernier, et al.. (2024). Multidimensional penalized splines for survival models: illustration for net survival trend analyses. International Journal of Epidemiology. 53(2).
2.
Mounier, Morgane, Cédric Rossi, S. Gauthier, et al.. (2023). Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study. Cancers. 15(15). 3885–3885. 3 indexed citations
3.
Rachet, Bernard, Édouard Cornet, Cédric Rossi, et al.. (2023). Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France. Cancer Medicine. 12(7). 8911–8923. 2 indexed citations
4.
Mounier, Morgane, Louis Arnould, Catherine Creuzot‐Garcher, et al.. (2021). Heamatological malignancies in giant cell arteritis: a French population-based study. Lara D. Veeken. 60(11). 5408–5412. 5 indexed citations
5.
Audia, Sylvain, et al.. (2020). Evans’ Syndrome: From Diagnosis to Treatment. Journal of Clinical Medicine. 9(12). 3851–3851. 53 indexed citations
6.
Romain, Gaëlle, Nadine Bossard, Laurent Remontet, et al.. (2019). Time-to-cure and cure proportion in solid cancers in France. A population based study. Cancer Epidemiology. 60. 93–101. 15 indexed citations
7.
Mounier, Morgane, S. Gauthier, Xavier Troussard, et al.. (2016). 5-Year Overall Survival and Progression-Free Survival in Multiple Myeloma by Line of Treatment from the French Hematologic Malignancy Registry. Value in Health. 19(7). A762–A762. 1 indexed citations
8.
Mounier, Morgane, Nadine Bossard, Laurent Remontet, et al.. (2015). Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5). The Lancet Haematology. 2(11). e481–e491. 29 indexed citations
9.
Rossi, Cédric, Jérémie Jegu, Morgane Mounier, et al.. (2015). Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Leukemia & lymphoma. 56(10). 2876–2882. 16 indexed citations
10.
Mounier, Morgane, et al.. (2015). A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years. Journal of Clinical Pharmacy and Therapeutics. 40(4). 391–397. 5 indexed citations
11.
Lopez, Anthony, Morgane Mounier, Anne‐Marie Bouvier, et al.. (2014). Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 12(8). 1324–1329. 71 indexed citations
12.
Mounier, Morgane, Julien Guy, Tony Petrella, et al.. (2014). The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry. Leukemia & lymphoma. 56(4). 1050–1057. 13 indexed citations
13.
Sant, Milena, Pamela Minicozzi, Morgane Mounier, et al.. (2014). Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. The Lancet Oncology. 15(9). 931–942. 209 indexed citations
14.
Bouvier, Anne‐Marie, P. Arveux, Isabelle Baldi, et al.. (2013). What are the delays in providing cancer care in France? A study based on data from cancer registries.. 581–589. 1 indexed citations
15.
16.
Minello, Anne, Catherine Quantin, Valérie Jooste, et al.. (2011). Chronic viral hepatitis and risk of lymphoid malignancies: A retrospective twelve-year population-based cohort study in Côte d’Or, France. Digestive and Liver Disease. 44(2). 160–165. 5 indexed citations
17.
Maynadié, Marc, François Girodon, Morgane Mounier, et al.. (2010). Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica. 96(1). 55–61. 63 indexed citations
18.
Girodon, François, Céline Schaeffer, Morgane Mounier, et al.. (2009). Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 94(6). 865–869. 35 indexed citations
19.
Girodon, François, Céline Schaeffer, Cédric Cleyrat, et al.. (2008). Frequent Reduction or Absence of Detection of the JAK2-Mutated Clone in JAK2V617F-Positive Patients within the First Years of Hydroxyurea Therapy. Blood. 112(11). 5225–5225. 13 indexed citations
20.
Girodon, François, Céline Schaeffer, Cédric Cleyrat, et al.. (2008). Frequent reduction or absence of detection of the JAK2-mutated clone in JAK2V617F-positive patients within the first years of hydroxyurea therapy. Haematologica. 93(11). 1723–1727. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. H. Goldstone Breakdown of academic impact, for papers by A. Grigg Breakdown of academic impact, for papers by Adina Cioc Breakdown of academic impact, for papers by Marie‐Christine Jacob Breakdown of academic impact, for papers by Anastasios Raptis Breakdown of academic impact, for papers by Chirayu Auewarakul Breakdown of academic impact, for papers by Beenu Thakral Breakdown of academic impact, for papers by Roni Tamari Breakdown of academic impact, for papers by Fabrice Monpoux Breakdown of academic impact, for papers by Usama Gergis
Rankless by CCL
2026